These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3065464)

  • 41. Guillain-Barré syndrome in Larimer County, Colorado: a high-incidence area.
    Kaplan JE; Poduska PJ; McIntosh GC; Hopkins RS; Ferguson SW; Schonberger LB
    Neurology; 1985 Apr; 35(4):581-4. PubMed ID: 3982649
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sources of error in the diagnosis of Guillain-Barre syndrome.
    Feit H; Tindall RS; Glasberg M
    Muscle Nerve; 1982 Feb; 5(2):111-7. PubMed ID: 6122160
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased incidence of Guillain-Barré syndrome postpartum.
    Cheng Q; Jiang GX; Fredrikson S; Link H; de Pedro-Cuesta J
    Epidemiology; 1998 Nov; 9(6):601-4. PubMed ID: 9799167
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuromuscular respiratory failure in Guillain-Barre Syndrome: evaluation of clinical and electrodiagnostic predictors.
    Sundar U; Abraham E; Gharat A; Yeolekar ME; Trivedi T; Dwivedi N
    J Assoc Physicians India; 2005 Sep; 53():764-8. PubMed ID: 16334619
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rapid recovery of a child with Guillain-Barré syndrome using intravenous immunoglobulins.
    Shah M; Weinberger M
    J La State Med Soc; 1998 Nov; 150(11):533-7. PubMed ID: 9861805
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Guillain-Barré syndrome in South-West Stockholm, 1973-1991, 3. Clinicoepidemiological subgroups.
    de Pedro-Cuesta J; Abraira V; Jiang GX; Solders G; Fredrikson S
    Acta Neurol Scand; 1996; 93(2-3):175-83. PubMed ID: 8741139
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Age-associated changes in the symptomatology of Guillain-Barré syndrome in children.
    Sakakihara Y; Kamoshita S
    Dev Med Child Neurol; 1991 Jul; 33(7):611-6. PubMed ID: 1652528
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinico-electrophysiological profile and predictors of functional outcome in Guillain-Barre syndrome (GBS).
    Verma R; Chaudhari TS; Raut TP; Garg RK
    J Neurol Sci; 2013 Dec; 335(1-2):105-11. PubMed ID: 24064258
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ventilatory drive and carbon dioxide response in ventilatory failure due to myasthenia gravis and Guillain-Barré syndrome.
    Borel CO; Teitelbaum JS; Hanley DF
    Crit Care Med; 1993 Nov; 21(11):1717-26. PubMed ID: 8222689
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Japanese clinical statistical data of patients with Guillain-Barre syndrome].
    Okiyama R; Furukawa T
    Nihon Rinsho; 1992 Nov; 50 Suppl():161-7. PubMed ID: 1344345
    [No Abstract]   [Full Text] [Related]  

  • 51. Exposure to exogenous gangliosides and Guillain-Barré syndrome.
    Beghi E
    Neuroepidemiology; 1995; 14(2):45-8. PubMed ID: 7891813
    [No Abstract]   [Full Text] [Related]  

  • 52. Simultaneous outbreaks of Guillain-Barré syndrome and Bell's palsy in Hawaii in 1981.
    Kaplan JE; Greenspan JR; Bomgaars M; Wiebenga N; Bart RD; Robbins K; Wiebe R; Tabrah F; Stewart J; Schonberger LB
    JAMA; 1983 Nov; 250(19):2635-40. PubMed ID: 6313978
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Bilateral peripheral facial paralysis and Guillain-Barré syndrome].
    García Callejo FJ; Velert Vila MM; Pardo Mateu L; Mallea Cañizares I; Marco Algarra J
    Acta Otorrinolaringol Esp; 1998 Oct; 49(7):561-8. PubMed ID: 9866223
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Axonal variant of Guillain-Barre syndrome associated with Campylobacter infection in Bangladesh.
    Islam Z; Jacobs BC; van Belkum A; Mohammad QD; Islam MB; Herbrink P; Diorditsa S; Luby SP; Talukder KA; Endtz HP
    Neurology; 2010 Feb; 74(7):581-7. PubMed ID: 20157160
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epidemiologic and clinical features of the Guillain-Barre' syndrome in Sardinia in the 1961-1980 period.
    Congia S; Melis M; Carboni MA
    Acta Neurol (Napoli); 1989 Feb; 11(1):15-20. PubMed ID: 2718810
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies.
    Ho TW; Mishu B; Li CY; Gao CY; Cornblath DR; Griffin JW; Asbury AK; Blaser MJ; McKhann GM
    Brain; 1995 Jun; 118 ( Pt 3)():597-605. PubMed ID: 7600081
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epidemiological features of Guillain-Barré syndrome in Sweden, 1978-93.
    Jiang GX; Cheng Q; Link H; de Pedro-Cuesta J
    J Neurol Neurosurg Psychiatry; 1997 May; 62(5):447-53. PubMed ID: 9153599
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High-dose intravenous immune globulin in the management of severe Guillain-Barre syndrome.
    Baskin E; Turkay S; Icagasioglu D; Tanzer F; Cevit O
    Turk J Pediatr; 1996; 38(1):119-23. PubMed ID: 8819632
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An epidemiologic and clinical evaluation of Guillain-Barré syndrome reported in association with the administration of swine influenza vaccines.
    Langmuir AD; Bregman DJ; Kurland LT; Nathanson N; Victor M
    Am J Epidemiol; 1984 Jun; 119(6):841-79. PubMed ID: 6328974
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study.
    Ruts L; Drenthen J; Jacobs BC; van Doorn PA;
    Neurology; 2010 May; 74(21):1680-6. PubMed ID: 20427754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.